RedHill Bio reports last patient out for Phase 2/3 COVID-19 study of oral opaganib
July 19 2021 - 6:50AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From Apr 2024 to May 2024
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From May 2023 to May 2024